Clinical Trials
415 trialsSPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
City of Hope Medical Center
Virtual Agent Feasibility in Oncology Patients (NTT Data)
Duke University
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
CureVac
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
Sichuan University
Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer
National Institutes of Health Clinical Center (CC)
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
Fudan University
Perioperative Immunotherapy for NSCLC (ECTOP-1030)
Fudan University
Lung Cancer Screening CT for Firefighters
University of California, San Francisco
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
INDIGO
Gustave Roussy, Cancer Campus, Grand Paris
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
CheckCell-2
Intima Bioscience, Inc.
ARTIA-Lung
Varian, a Siemens Healthineers Company
EPIC
Therakos LLC
Neo-Kan
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AI-Lung
University of Florida
BIB 01
Institut Bergonié
EMPIRE
Institut Bergonié
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Sutro Biopharma, Inc.
TUXEDO-5
MedSIR
CH:II
Lady Davis Institute
Vaccination of Advanced-Stage Lung Cancer Patients
University of Arkansas
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
National Institutes of Health Clinical Center (CC)
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
Defining Musical Toxicity and Its Effect on Patient Well-being
Mayo Clinic
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
Memorial Sloan Kettering Cancer Center
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
M.D. Anderson Cancer Center
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
Wake Forest University Health Sciences
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Rutgers, The State University of New Jersey
LUNGadenosine
Centre Hospitalier Universitaire de Nice
Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer
Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation
Allist Pharmaceuticals, Inc.
ELEVATE
Prisma Health-Midlands
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ImmunityBio, Inc.
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
ImmunityBio, Inc.
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
Pfizer
A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions
Auris Health, Inc.
A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors
Astellas Pharma Inc
Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block
Shanghai Pulmonary Hospital, Shanghai, China
Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases
University of Texas Southwestern Medical Center
POIMS
University of Kansas Medical Center
NEGOTIATE
Sun Yat-sen University
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
APPEAL
Sun Yat-sen University
AERESA
Sun Yat-sen University
SBRT_LOV
Universitair Ziekenhuis Brussel